InsidersTradesSigma
Follow the 셀바이오휴먼텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Food & Beverage sector, 셀바이오휴먼텍 has published 3 reports. Market capitalisation: €50.8bn. The latest transaction was filed on 7 April 2026 (Purchase). Among the most active insiders: 이권선. All data is free.
3
Insider Decl.
n/a
Thresholds
€63,266
3 ops.
Buy Volume
n/a
n/a
Sell Volume
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,964 of 29,062 companies
66.5
score / 100
Value66
Quality67
FCF yld-10%
Earn yld17%
EV/EBITDA6.1x
ROE17%
Gross mgn37%
Net mgn17%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Declarations3 total
3 of 3 declarations
关于 셀바이오휴먼텍
Selbiohumantech 是一家在 XKRX 上市的农业食品公司。它专注于创新食品的开发。